| Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort … S Yusuf, P Joseph, S Rangarajan, S Islam, A Mente, P Hystad, M Brauer, ... The Lancet 395 (10226), 795-808, 2020 | 1763 | 2020 |
| Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors P Joseph, D Leong, M McKee, SS Anand, JD Schwalm, K Teo, A Mente, ... Circulation research 121 (6), 677-694, 2017 | 1116 | 2017 |
| Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study GR Dagenais, DP Leong, S Rangarajan, F Lanas, P Lopez-Jaramillo, ... The Lancet 395 (10226), 785-794, 2020 | 730 | 2020 |
| Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study A Rosengren, A Smyth, S Rangarajan, C Ramasundarahettige, ... The Lancet Global Health 7 (6), e748-e760, 2019 | 597 | 2019 |
| A citywide protocol for primary PCI in ST-segment elevation myocardial infarction MR Le May, DY So, R Dionne, CA Glover, MPV Froeschl, GA Wells, ... New England Journal of Medicine 358 (3), 231-240, 2008 | 543 | 2008 |
| Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease DP Leong, PG Joseph, M McKee, SS Anand, KK Teo, JD Schwalm, ... Circulation research 121 (6), 695-710, 2017 | 436 | 2017 |
| Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial PJ Devereaux, E Duceppe, G Guyatt, V Tandon, R Rodseth, BM Biccard, ... The Lancet 391 (10137), 2325-2334, 2018 | 334 | 2018 |
| Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a … M Walli-Attaei, P Joseph, A Rosengren, CK Chow, S Rangarajan, SA Lear, ... The Lancet 396 (10244), 97-109, 2020 | 319 | 2020 |
| Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study A Mente, M Dehghan, S Rangarajan, M McQueen, G Dagenais, ... The lancet Diabetes & endocrinology 5 (10), 774-787, 2017 | 305 | 2017 |
| Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial FK Borges, M Bhandari, E Guerra-Farfan, A Patel, A Sigamani, M Umer, ... The Lancet 395 (10225), 698-708, 2020 | 296 | 2020 |
| Polypill with or without aspirin in persons without cardiovascular disease S Yusuf, P Joseph, A Dans, P Gao, K Teo, D Xavier, P López-Jaramillo, ... New England Journal of Medicine 384 (3), 216-228, 2021 | 271 | 2021 |
| Health-related quality of life and mortality in heart failure: the global congestive heart failure study of 23 000 patients from 40 countries I Johansson, P Joseph, K Balasubramanian, JJV McMurray, LH Lund, ... Circulation 143 (22), 2129-2142, 2021 | 233 | 2021 |
| Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an … MW Attaei, R Khatib, M McKee, S Lear, G Dagenais, EU Igumbor, ... The Lancet Public Health 2 (9), e411-e419, 2017 | 228 | 2017 |
| Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized … R Khatib, P Joseph, M Briel, S Yusuf, J Healey International journal of cardiology 165 (1), 17-24, 2013 | 160 | 2013 |
| Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis P Joseph, G Roshandel, P Gao, P Pais, E Lonn, D Xavier, A Avezum, ... The Lancet 398 (10306), 1133-1146, 2021 | 152 | 2021 |
| Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool ZN Sohani, D Meyre, RJ de Souza, PG Joseph, M Gandhi, BB Dennis, ... Bmc Genetics 16, 1-8, 2015 | 137 | 2015 |
| Imaging atherosclerosis with positron emission tomography P Joseph, A Tawakol European heart journal 37 (39), 2974-2980, 2016 | 123 | 2016 |
| Accelerated care versus standard care among patients with hip fracture: the HIP ATTACK pilot trial Hip Fracture Accelerated Surgical Treatment and Care Track (HIP ATTACK ... Canadian Medical Association Journal 186 (1), E52-E60, 2014 | 117 | 2014 |
| Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy S Li, Z Liu, P Joseph, B Hu, L Yin, LA Tse, S Rangarajan, C Wang, ... European Heart Journal 43 (30), 2852-2863, 2022 | 102 | 2022 |
| Safety of continuing trastuzumab despite mild cardiotoxicity: a phase I trial DP Leong, T Cosman, MM Alhussein, N Kumar Tyagi, S Karampatos, ... Cardio Oncology 1 (1), 1-10, 2019 | 88 | 2019 |
